Metropolitan Life Insurance Company (MetLife)’s OptimizeRx OPRX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-925	Closed	-$11.2K	–	1476
2024 Q1	$11.2K	Hold	925	–	–	﹤0.01%	2090
2023 Q4	$13.2K	Hold	925	–	–	﹤0.01%	2080
2023 Q3	$7.2K	Hold	925	–	–	﹤0.01%	2348
2023 Q2	$13.2K	Buy	925 +298	+48%	+$4.24K	﹤0.01%	2145
2023 Q1	$9.17K	Sell	627 -479	-43%	-$8.02K	﹤0.01%	2190
2022 Q4	$18.6K	Hold	1,106	–	–	﹤0.01%	2052
2022 Q3	$16.4K	Hold	1,106	–	–	﹤0.01%	2120
2022 Q2	$30.3K	Hold	1,106	–	–	﹤0.01%	1813
2022 Q1	$41.7K	Sell	1,106 -3,371	-75%	-$149K	﹤0.01%	1698
2021 Q4	$278K	Hold	4,477	–	–	﹤0.01%	1786
2021 Q3	$383K	Sell	4,477 -673	-13%	-$42.2K	0.01%	1625
2021 Q2	$319K	Hold	5,150	–	–	﹤0.01%	1813
2021 Q1	$251K	Hold	5,150	–	–	﹤0.01%	1860
2020 Q4	$160K	Hold	5,150	–	–	﹤0.01%	2086
2020 Q3	$107K	Buy	+5,150	New	+$88.4K	﹤0.01%	2174

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OPRX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 925 shares — an estimated $11.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OPRX in Q3 2020 and held it in 15 quarters. The position peaked at $383K in Q3 2021. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 925 OptimizeRx shares in Q2 2024, an estimated $11.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in OptimizeRx in Q3 2020 and held it in 15 quarters.
Metropolitan Life Insurance Company (MetLife)'s OptimizeRx position peaked at $383K in Q3 2021.
92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.